240 related articles for article (PubMed ID: 32657026)
1. Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study.
Xu W; Tan L; Su BJ; Yu H; Bi YL; Yue XF; Dong Q; Yu JT
Alzheimers Dement; 2020 Aug; 16(8):1146-1152. PubMed ID: 32657026
[TBL] [Abstract][Full Text] [Related]
2. Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Wang ZT; Li KY; Tan CC; Xu W; Shen XN; Cao XP; Wang P; Bi YL; Dong Q; Tan L; Yu JT
J Alzheimers Dis; 2021; 82(3):1045-1054. PubMed ID: 34151793
[TBL] [Abstract][Full Text] [Related]
3. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
[TBL] [Abstract][Full Text] [Related]
4. Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Ma YH; Wu JH; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Feng L; Tan L; Yu JT
J Alzheimers Dis; 2020; 77(1):411-421. PubMed ID: 32804140
[TBL] [Abstract][Full Text] [Related]
5. Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: the CABLE study.
Li QY; Hu HY; Zhang GW; Hu H; Ou YN; Huang LY; Wang AY; Gao PY; Ma LY; Tan L; Yu JT
Alzheimers Res Ther; 2024 Feb; 16(1):28. PubMed ID: 38321520
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
7. Associations of sleep characteristics with alpha-synuclein in cerebrospinal fluid in older adults.
Wang XT; Liu FT; Bi YL; Shen XN; Xu W; Wang J; Tan L; Yu JT
Ann Clin Transl Neurol; 2020 Oct; 7(10):2026-2034. PubMed ID: 32949229
[TBL] [Abstract][Full Text] [Related]
8. Sleep Characteristics and Cognitive Function in Older Adults Without Dementia: The CABLE Study.
Fu Y; Wang ZT; Qu Y; Wang XT; Ma YH; Bi YL; Dong Q; Tan L; Yu JT
J Alzheimers Dis; 2021; 84(3):1029-1038. PubMed ID: 34602483
[TBL] [Abstract][Full Text] [Related]
9. Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.
Osorio RS; Ducca EL; Wohlleber ME; Tanzi EB; Gumb T; Twumasi A; Tweardy S; Lewis C; Fischer E; Koushyk V; Cuartero-Toledo M; Sheikh MO; Pirraglia E; Zetterberg H; Blennow K; Lu SE; Mosconi L; Glodzik L; Schuetz S; Varga AW; Ayappa I; Rapoport DM; de Leon MJ
Sleep; 2016 Jun; 39(6):1253-60. PubMed ID: 26951396
[TBL] [Abstract][Full Text] [Related]
10. Association between Life's Simple 7 and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: the CABLE study.
Zhao YL; Ou YN; Ma YH; Huang YY; Bi YL; Tan L; Yu JT
Alzheimers Res Ther; 2022 May; 14(1):74. PubMed ID: 35619174
[TBL] [Abstract][Full Text] [Related]
11. Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
Li LL; Ma YH; Bi YL; Sun FR; Hu H; Hou XH; Xu W; Shen XN; Dong Q; Tan L; Yang JL; Yu JT
J Alzheimers Dis; 2021; 81(1):389-401. PubMed ID: 33814427
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.
Mander BA; Dave A; Lui KK; Sprecher KE; Berisha D; Chappel-Farley MG; Chen IY; Riedner BA; Heston M; Suridjan I; Kollmorgen G; Zetterberg H; Blennow K; Carlsson CM; Okonkwo OC; Asthana S; Johnson SC; Bendlin BB; Benca RM
Sleep; 2022 Sep; 45(9):. PubMed ID: 35670275
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients.
Knapskog AB; Eldholm RS; Braekhus A; Engedal K; Saltvedt I
BMC Geriatr; 2017 Sep; 17(1):210. PubMed ID: 28893185
[TBL] [Abstract][Full Text] [Related]
15. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP
Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185
[TBL] [Abstract][Full Text] [Related]
16. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
17. Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study.
Hu HY; Ma LZ; Hu H; Bi YL; Ma YH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
Neurotox Res; 2021 Aug; 39(4):1372-1380. PubMed ID: 34097185
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
[TBL] [Abstract][Full Text] [Related]
19. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Zhang PF; Wang ZT; Liu Y; Hu H; Sun Y; Hu HY; Ma YH; Tan L; Yu JT
J Alzheimers Dis; 2022; 87(2):721-730. PubMed ID: 35342094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
